Effect of variable domain charge on in vitro and in vivo disposition of monoclonal antibodies
A growing body of evidence supports the important role of molecular charge on antibody pharmacokinetics (PK), yet a quantitative description of the effect of charge on systemic and tissue disposition of antibodies is still lacking. Consequently, we have systematically engineered complementarity-dete...
Main Authors: | Shufang Liu, Ashwni Verma, Hubert Kettenberger, Wolfgang F. Richter, Dhaval K. Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2021.1993769 |
Similar Items
-
Pulmonary Pharmacokinetics of Antibody and Antibody Fragments Following Systemic and Local Administration in Mice
by: Prabhas Jagdale, et al.
Published: (2024-09-01) -
Inter-Antibody Variability in the Clinical Pharmacokinetics of Monoclonal Antibodies Characterized Using Population Physiologically Based Pharmacokinetic Modeling
by: Mokshada Kumar, et al.
Published: (2024-07-01) -
A Cell-Level Systems PK-PD Model to Characterize In Vivo Efficacy of ADCs
by: Aman P. Singh, et al.
Published: (2019-02-01) -
Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain
by: Young D. Kwon, et al.
Published: (2023-12-01) -
Global characterization of modifications to the charge isomers of IgG antibody
by: Xinling Cui, et al.
Published: (2022-02-01)